Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9289706rdf:typepubmed:Citationlld:pubmed
pubmed-article:9289706lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9289706lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:9289706lifeskim:mentionsumls-concept:C0020473lld:lifeskim
pubmed-article:9289706lifeskim:mentionsumls-concept:C0242599lld:lifeskim
pubmed-article:9289706pubmed:issue19-22lld:pubmed
pubmed-article:9289706pubmed:dateCreated1997-9-5lld:pubmed
pubmed-article:9289706pubmed:abstractTextChemotaxis, spontaneous migration, phagocytosis, expression of the receptors of Fc Ig fragments and of C3 component of complement has been examined in blood of 51 patients with obesity divided into 3 groups with: 1. disturbances in carbohydrate and lipid metabolism, 2. disturbance in lipid metabolism, 3. no symptoms of metabolic diseases and 20 healthy controls. A comparison of the characteristics of neutral granulocytes in the blood of the healthy controls before and after fat rich meal has been performed. Obtained results indicate that high concentration of lipids, decrease granulocyte activity therefore could be the cause of the decrease of immunological defence.lld:pubmed
pubmed-article:9289706pubmed:languagepollld:pubmed
pubmed-article:9289706pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9289706pubmed:citationSubsetIMlld:pubmed
pubmed-article:9289706pubmed:statusMEDLINElld:pubmed
pubmed-article:9289706pubmed:monthMaylld:pubmed
pubmed-article:9289706pubmed:issn0032-3756lld:pubmed
pubmed-article:9289706pubmed:authorpubmed-author:PietruskaZZlld:pubmed
pubmed-article:9289706pubmed:authorpubmed-author:Ku?maAAlld:pubmed
pubmed-article:9289706pubmed:authorpubmed-author:Debczy?skiWWlld:pubmed
pubmed-article:9289706pubmed:issnTypePrintlld:pubmed
pubmed-article:9289706pubmed:volume51lld:pubmed
pubmed-article:9289706pubmed:ownerNLMlld:pubmed
pubmed-article:9289706pubmed:authorsCompleteYlld:pubmed
pubmed-article:9289706pubmed:pagination269-71lld:pubmed
pubmed-article:9289706pubmed:dateRevised2008-6-20lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:meshHeadingpubmed-meshheading:9289706-...lld:pubmed
pubmed-article:9289706pubmed:year1996lld:pubmed
pubmed-article:9289706pubmed:articleTitle[Examination of human neutrophil activation in hyperlipidemia].lld:pubmed
pubmed-article:9289706pubmed:affiliationZak?adu Immunopatologii AM w Bia?ymstoku.lld:pubmed
pubmed-article:9289706pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9289706pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9289706pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:9289706pubmed:publicationTypeControlled Clinical Triallld:pubmed